1. Home
  2. CALC vs FAT Comparison

CALC vs FAT Comparison

Compare CALC & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • FAT
  • Stock Information
  • Founded
  • CALC 2011
  • FAT 2017
  • Country
  • CALC United States
  • FAT United States
  • Employees
  • CALC N/A
  • FAT N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • CALC Health Care
  • FAT Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • FAT Nasdaq
  • Market Cap
  • CALC 48.1M
  • FAT 44.0M
  • IPO Year
  • CALC N/A
  • FAT 2017
  • Fundamental
  • Price
  • CALC $2.91
  • FAT $1.97
  • Analyst Decision
  • CALC Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • CALC 2
  • FAT 1
  • Target Price
  • CALC $14.50
  • FAT $10.00
  • AVG Volume (30 Days)
  • CALC 91.2K
  • FAT 78.0K
  • Earning Date
  • CALC 08-12-2025
  • FAT 07-30-2025
  • Dividend Yield
  • CALC N/A
  • FAT 7.11%
  • EPS Growth
  • CALC N/A
  • FAT N/A
  • EPS
  • CALC N/A
  • FAT N/A
  • Revenue
  • CALC N/A
  • FAT $577,500,000.00
  • Revenue This Year
  • CALC N/A
  • FAT N/A
  • Revenue Next Year
  • CALC N/A
  • FAT $8.68
  • P/E Ratio
  • CALC N/A
  • FAT N/A
  • Revenue Growth
  • CALC N/A
  • FAT 0.96
  • 52 Week Low
  • CALC $1.42
  • FAT $1.95
  • 52 Week High
  • CALC $5.97
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CALC 52.85
  • FAT 27.84
  • Support Level
  • CALC $2.31
  • FAT $1.95
  • Resistance Level
  • CALC $3.00
  • FAT $2.18
  • Average True Range (ATR)
  • CALC 0.34
  • FAT 0.14
  • MACD
  • CALC -0.12
  • FAT -0.02
  • Stochastic Oscillator
  • CALC 40.00
  • FAT 3.08

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: